Rituximab combined with autologous peripheral blood stem cell transplantation improve therapeutic effects of chemotherapy in pediatric patients with Burkitt's lymphoma.

Source:http://linkedlifedata.com/resource/pubmed/id/20065046

Download in:

View as

General Info

PMID
20065046